Corium International Company

Corium International engages in the development of advanced transdermal drug delivery technologies and products. Corium International is a privately-owned company engaged in the research, development and manufacture of advanced transdermal drug delivery technologies and products. Using its proprietary delivery technologies and its development and manufacturing expertise, Corium has developed a number of active and passive transdermal products with enhanced therapeutic or safety profiles. This self-funded product pipeline spans several therapeutic areas and is in various stages of development. Corium also has several partner-funded products with small, medium and large pharmaceutical companies in various stages of development, ranging from manufacturing to research and development.
Technology: Preventive Medicine
Industry: Precision Medicine
Headquarters: Menlo Park
Founded Date: 1995
Employees Number: 501-1000
Funding Status: M&A

Visit Website
Register and Claim Ownership